A detailed history of Zurich Insurance Group LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Zurich Insurance Group LTD holds 273,685 shares of GILD stock, worth $24.7 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
273,685
Previous 30,700 791.48%
Holding current value
$24.7 Million
Previous $2.11 Million 989.27%
% of portfolio
0.2%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$66.59 - $83.99 $16.2 Million - $20.4 Million
242,985 Added 791.48%
273,685 $22.9 Million
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $2.27 Million - $2.48 Million
30,700 New
30,700 $2.3 Million
Q2 2022

Aug 15, 2022

BUY
$57.72 - $65.01 $1.38 Million - $1.55 Million
23,900 New
23,900 $1.48 Million
Q4 2019

Feb 14, 2020

SELL
$61.62 - $67.78 $15.8 Million - $17.4 Million
-256,609 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$62.51 - $69.0 $536,273 - $591,951
8,579 Added 3.46%
256,609 $16.3 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $2.54 Million - $2.85 Million
41,097 Added 19.86%
248,030 $16.8 Million
Q1 2019

May 15, 2019

SELL
$62.53 - $70.05 $2.57 Million - $2.88 Million
-41,127 Reduced 16.58%
206,933 $13.5 Million
Q4 2018

Feb 14, 2019

BUY
$60.54 - $79.0 $214,432 - $279,818
3,542 Added 1.45%
248,060 $15.5 Million
Q3 2018

Nov 14, 2018

BUY
$71.28 - $78.92 $1.92 Million - $2.12 Million
26,871 Added 12.35%
244,518 $18.9 Million
Q2 2018

Aug 14, 2018

SELL
$64.88 - $75.68 $1.71 Million - $1.99 Million
-26,357 Reduced 10.8%
217,647 $15.4 Million
Q1 2018

May 15, 2018

BUY
$72.84 - $88.8 $4.15 Million - $5.06 Million
56,961 Added 30.45%
244,004 $18.4 Million
Q4 2017

Feb 14, 2018

BUY
$71.15 - $83.52 $1.53 Million - $1.79 Million
21,488 Added 12.98%
187,043 $13.4 Million
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $11.9 Million - $14.1 Million
165,555
165,555 $13.4 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Zurich Insurance Group LTD Portfolio

Follow Zurich Insurance Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurich Insurance Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Zurich Insurance Group LTD with notifications on news.